You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.


The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
 
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

Charities call for more investment in medical research

By Dermot - 27th Nov 2015 | 9 views

The MRCG said such a move would be needed if patients are not to miss out on new cures and treatments.

“Medical research has been pivotal in increasing life expectancy, reducing infant mortality, limiting the toll of infectious diseases, and improving outcomes for patients,” said Mr Philip Watt, Chairperson of the Medical Research Charities Group.

“Clearly, without significant investment, Irish patients will be left at a serious disadvantage. Patients in very challenging disease areas will have to go abroad if they want to access clinical trials for promising therapies that could make a huge difference to their lives.

“Patients will also be left in the slow lane when it comes to accessing treatments and therapies in the early stages of development. It is simply not right that Irish patients should be treated as second class to citizens in other European countries that really are pushing the boundaries and the possibilities of research.”

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]